The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity. - Wikidata - awgldk - TriplyDB

The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity.

The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity.

http://www.wikidata.org/entity/Q38987399

about

Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer Drugs A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo Proteomic studies on anti-tumor agent ansamitocin P-3 producer Actinosynnema pretiosum in response to ammonium and isobutanol.Antibody-Drug Conjugates (ADCs) for Personalized Treatment of Solid Tumors: A Review.Cancer chemotherapy agents target intratumoral dendritic cells to potentiate antitumor immunity.Recent Developments in ADC Technology: Preclinical Studies Signal Future Clinical Trends.Trial watch: Dendritic cell-based anticancer immunotherapy.Discovery of a Novel Microtubule Targeting Agent as an Adjuvant for Cancer Immunotherapy

P2860

Q26781522-A931CDF3-5E83-497E-8C78-811D1E96DD28 Q30665888-896E3F41-02A1-41FA-B37D-C4B9E89BDD28 Q36337533-2D071481-4DF3-47F7-AB30-2A3E46242BB4 Q39210427-00DB3E00-AA8A-4A54-8364-A6B479C03427 Q41545176-DFFAB38D-E99C-480C-9771-0A993BC08581 Q45728543-4A90461A-E341-4CB3-9531-2BDAC3D7604F Q53109846-EEE98F15-B2D8-49B2-B40B-0B84CA4B0019 Q58575086-62B0FBAC-1F92-4948-A4B2-CB934C6F8A4C

P2860

The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity.

http://www.wikidata.org/entity/Q38987399

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

The microtubule-depolymerizing ...... enhanced anti-tumor immunity.

@en

type

label

The microtubule-depolymerizing ...... enhanced anti-tumor immunity.

@en

prefLabel

The microtubule-depolymerizing ...... enhanced anti-tumor immunity.

@en

P1433

Q38987399-2770F7BD-59BF-4405-B294-18C1D7567674

P1476

Q38987399-62527FD2-9612-4C07-B32D-0DA84BEE1227

P2093

Q38987399-10F6FD95-CE37-4CCA-973D-87EB8209AB42

Q38987399-4927F635-42A9-43F3-80FC-366FE8CEC358

Q38987399-67AA0A2D-4F97-4DE0-A28A-81DF31EF6C45

Q38987399-BB45D8BB-19E4-4C2F-A889-18B962E5C877

Q38987399-DC737F2B-B23C-4226-9E1A-132C430D0D31

Q38987399-F04E805E-11EF-46AD-9317-CB0C8866C914

P2860

Q38987399-003240A7-507E-4340-94BA-857719527DC0

Q38987399-00914DF9-84FE-42C0-88FD-696AEDA5FF03

Q38987399-0A9BAAA9-86C0-46D8-98C4-C339B0656553

Q38987399-0B16FC1D-9129-408C-8047-874BF7AEEE62

Q38987399-10C5DBE5-D4CC-44DF-A117-97906466F0F2

Q38987399-16BEAC60-321A-4182-8FC3-44881D284654

Q38987399-182EABDD-7A87-43C3-A2C4-8C2A37E58414

Q38987399-20C3B813-0428-487B-94D9-F4026AE49DF7

Q38987399-212B0368-DF5C-42FC-9FE6-13160639F019

Q38987399-2333FDC4-B65B-4B44-AAD3-0718A7442B1F

P2888

Q38987399-EDB2007B-180D-4C0A-8EC4-B3741E63E05E

P304

Q38987399-012932C8-148C-48DA-93CB-80DA1DDA6458

P31

Q38987399-7A7F70B7-E6B0-4ED4-A400-AD58CC243C64

P356

Q38987399-10D11024-55DF-4726-912D-99C145694D91

P433

Q38987399-485E24FF-2433-4B4C-96C9-DAD0E81DB2FF

P478

Q38987399-73FED5EC-955D-4955-B198-B40434673BA0

P50

Q38987399-04CF21FC-0B7B-465D-B4C7-93120FD65381

Q38987399-1B62D71F-B98D-4056-A375-B2128D9D18BC

P577

Q38987399-92F59ADC-2D3F-43CF-81B5-E8A6895298DA

P5875

Q38987399-065045BD-566F-426A-89A1-A455E06693C7

P6179

Q38987399-4F404FB5-527E-4BD0-9398-EE71D1DF5384

P698

Q38987399-94E55222-6B6B-4C92-8155-E17D538A852C

P356

S00262-014-1565-4

P1433

Cancer Immunology, Immunotherapy

P1476

The microtubule-depolymerizing ...... d enhanced anti-tumor immunity

@en

P2093

Alfred Zippelius

http://www.w3.org/2001/XMLSchema#string

Didier Lardinois

http://www.w3.org/2001/XMLSchema#string

Jens Schreiner

http://www.w3.org/2001/XMLSchema#string

Philipp Müller

http://www.w3.org/2001/XMLSchema#string

Spasenija Savic Prince

http://www.w3.org/2001/XMLSchema#string

Viola A Heinzelmann-Schwarz

http://www.w3.org/2001/XMLSchema#string

P2860

Innate and adaptive immune cells in the tumor microenvironment

Molecular mechanism of action of microtubule-stabilizing anticancer agents

Dendritic cells and the control of immunity

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

Macrophage plasticity and polarization: in vivo veritas

Cancer immunotherapy via dendritic cells

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

Immunogenic cell death in cancer therapy

Differential effects of Paclitaxel on dendritic cell function.

Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer

P2888

s00262-014-1565-4

P304

925-938

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00262-014-1565-4

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

Daniela S Thommen

P577

2014-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262929318

http://www.w3.org/2001/XMLSchema#string

P6179

1052959911

http://www.w3.org/2001/XMLSchema#string

P698

24906866

http://www.w3.org/2001/XMLSchema#string